Life sciences companies are facing increasing pressure to produce innovative treatments and cures while meeting financial objectives. While doing business in emerging markets has the potential for significant cost savings and new revenue streams, there are pitfalls. Regardless of their location, life sciences companies are likely to face a great deal of upheaval as they strive to reinvent their strategies to achieve success.
The professionals at Deloitte member firms understand the challenges facing the Life Sciences and Health Care industry. Contact us to learn more and be sure to read the related research and reports on this page.
Featured Content
 |
Protecting and promoting life sciences in emerging markets
Innovation plays an essential role in addressing global health care needs. In an effort to increase innovation capacity and reduce development time and cost, life sciences firms are turning to emerging markets as a source of research, development and production capabilities. |
Related Content

BIO2008 Annual International Convention
Learn about Deloitte's involvement at the Biotechnology Industry Organization's Annual Convention to be held June 17-20, 2008 in San Diego, CA, USA.

Life Sciences and Health Care Industry alerts
Sign up to receive email alerts from Deloitte Research.

Health Care Webcasts
Deloitte professionals discuss key Life Sciences and Health Care issues in the Dbriefs Webcasts series.
|